BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12726865)

  • 1. Chemosensitivity linked to p73 function.
    Irwin MS; Kondo K; Marin MC; Cheng LS; Hahn WC; Kaelin WG
    Cancer Cell; 2003 Apr; 3(4):403-10. PubMed ID: 12726865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
    Bergamaschi D; Gasco M; Hiller L; Sullivan A; Syed N; Trigiante G; Yulug I; Merlano M; Numico G; Comino A; Attard M; Reelfs O; Gusterson B; Bell AK; Heath V; Tavassoli M; Farrell PJ; Smith P; Lu X; Crook T
    Cancer Cell; 2003 Apr; 3(4):387-402. PubMed ID: 12726864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
    Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
    Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
    He Y; Fan SZ; Jiang YG
    Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting.
    Lunghi P; Costanzo A; Mazzera L; Rizzoli V; Levrero M; Bonati A
    Clin Cancer Res; 2009 Nov; 15(21):6495-502. PubMed ID: 19861456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [p53 mutations and resistance to chemotherapy: a stab in the back for p73?].
    Soussi T
    Bull Cancer; 2003 May; 90(5):383-6. PubMed ID: 12850759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
    Das S; Nama S; Antony S; Somasundaram K
    Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations and resistance to chemotherapy: A stab in the back for p73.
    Soussi T
    Cancer Cell; 2003 Apr; 3(4):303-5. PubMed ID: 12726854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73alpha regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents.
    Liang W; Lu C; Li J; Yin JQ; Zhao RC
    Toxicology; 2010 Mar; 270(1):49-56. PubMed ID: 20100536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of p73 gene on chemosensitivity of human lung adenocarcinoma cells H1299].
    He Y; Fan SZ; Jiang YG; Chen JM; Li ZP; Zhou P; Zhou YG
    Ai Zheng; 2004 Jun; 23(6):645-9. PubMed ID: 15191663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.
    Marin MC; Jost CA; Brooks LA; Irwin MS; O'Nions J; Tidy JA; James N; McGregor JM; Harwood CA; Yulug IG; Vousden KH; Allday MJ; Gusterson B; Ikawa S; Hinds PW; Crook T; Kaelin WG
    Nat Genet; 2000 May; 25(1):47-54. PubMed ID: 10802655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis.
    Lee JH; Sancar A
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10668-72. PubMed ID: 21628572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for the p53 homologue p73 in E2F-1-induced apoptosis.
    Irwin M; Marin MC; Phillips AC; Seelan RS; Smith DI; Liu W; Flores ER; Tsai KY; Jacks T; Vousden KH; Kaelin WG
    Nature; 2000 Oct; 407(6804):645-8. PubMed ID: 11034215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.